Asian Spectator

Men's Weekly

.

AweMed Series Sponsors Eczema Family Day 2025 to Support Singapore’s Sensitive Skin Community

SINGAPORE - Media OutReach Newswire - 3 July 2025 - AweMed®, a skincare brand developed in collaboration with local dermatologists and paediatricians, sponsored the Eczema Family Day 2025—a...

Next Generation Monitoring: Neumann Releases the KH 120 II

BERLIN, GERMANY - Media OutReach - 20 April 2023 - Neumann, one of the leading brands in pro audio, has announced the release of the KH 120 II studio monitor. Building upon the success of i...

Starstreet Precinct Celebrates Sustainable Easter with Refresh. Easter. Bunny Art Installation in Collaboration with emmaAparty and Fashion Clinic

Come and celebrate the return of "Bah Pau" rabbits to Starstreet Precinct – this time dressed in sustainable Fashion Clinic outfits! #RefreshEasterBunny #StarstreetXemmaAparty #Starstr...

Former Regional Head of Strategy and Innovation at Willis Towe...

SINGAPORE, Aug. 14, 2019 /PRNewswire-AsiaNet/ -- Rajesh brings 20+ years of experience in the financial services industry in APAC and will help Banks and Insurers unlock the value of context...

Amazon Singapore Celebrates the Success of Women Entrepreneurs this International Women's Day

SINGAPORE - Media OutReach - 6 March 2020 - This International Women's Day, Amazon Singapore is shining the spotlight on women entrepreneurs and celebrating their success st...

Melco’s Studio City Water Park listed among China’s top 100 novel attractions in 2023 Global Travel Play Book released by China Tourism Academy Mafengwo

MACAU SAR - Media OutReach Newswire - 31 January 2024 - Melco Resorts & Entertainment, a developer, owner, and operator of integrated resort facilities in Asia and Europe, is pleased ...

New Vehicle Displays, Experiences And Activations To Take Plac...

LOS ANGELES, Aug. 23, 2019 /PRNewswire-AsiaNet/ -- -- Major Automotive Partners Confirmed to Participate Onsite at Los Angeles Convention Center, Nov. 22 -- Dec. 1The Los Angeles Auto Show (...

Megan's Kitchen 2019 Fall Winter New Release: Homey Healthy yet Tasteful Meal in a Pot

Recommended by Michelin Guide for 8 Years in a Row HONG KONG, CHINA - Media OutReach - 3 October 2019 - Megan's Kitchen presents delicious yet wholesome hot pot...

Eisai to Present Latest Data on Pipeline Assets in the Area of Alzheimer's Disease and Dementia at the 13th Clinical Trials on Alzheimer's Disease Conference

TOKYO, Oct 28, 2020 - (JCN Newswire) - Eisai Co., Ltd. announced today that the company will conduct a total of 7 presentations, including the latest data of the investigational anti-amylo...

SinoMab Granted the Most Popular Newly Listed Company Award

HONG KONG, Jan 10, 2020 - (ACN Newswire) - SinoMab BioScience Limited ("SinoMab" or the "Company", together with its subsidiaries, the "Group"; stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases, is pleased to announce that the Group has won the title of the "Most Popular Newly Listed Company" at the 4th Hong Kong Golden Stocks Awards held in Shenzhen.

image

The 4th Hong Kong Golden Stocks Awards was jointly organized by Zhitongcaijing.com, China's leading information platform focusing on Hong Kong and US stock markets, and 10jka.com.cn. The "Most Popular Newly Listed Company" award aims at recognizing companies had been listed on Hong Kong Stock Exchange since 1 January 2019 with significant recognition from the industry, high participation of investors and excellent performance in capital markets. Being awarded the "Most Popular Newly Listed Company" demonstrates the industry and investors' close attention towards biotech industry and is a great encouragement and motivation for SinoMab's future success. SinoMab, as the first Hong Kong-listed local biopharmaceutical company, possesses several first-in-target and first-in-class drug candidates. As the drug candidate coming the closest to commercialization, the Company's flagship product SM03 is currently in Phase III clinical trial for RA in China and is expected to be marketed in 2021 the soonest. According to the latest statistics, approximately 300 patients have taken the treatment trial. Meanwhile, the Company has proactively carried out long-term development plan. Its Suzhou production base is expected to be put into operation by the end of 2021 to satisfy the commercialized production requirements of drug candidates in the future.

After three months of strict screening, the 4th Hong Kong Golden Stocks Awards attracted over 860 Hong Kong-listed companies to participate, covering emerging industries such as TMT and healthcare. The award is a recognition of SinoMab's R&D strengths, business model and industry influence from the market and investors and will help improving the Company's reputation in the capital market.

About SinoMab BioScience Limited SinoMab BioScience Limited ("SinoMab" or the "Company", stock code: 3681.HK) is dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases. The Company's flagship product SM03 is a potential global first-in-target mAb against CD22 for the treatment of rheumatoid arthritis and is currently in Phase III clinical trial for rheumatoid arthritis in China, which has been recognized as one of the significant special projects of Significant New Drugs Development of the Twelfth Five-Year Plan Period and the Thirteenth Five-Year Plan Period. In addition, the Company possesses other potential first-in-target and first-in-class drug candidates, some of which are already in clinical stage, with their indications covering rheumatoid arthritis, systemic lupus erythematosus, non-Hodgkin's lymphoma, asthma, and other diseases with major unmet clinical needs.

Copyright 2020 ACN Newswire. All rights reserved. www.acnnewswire.com

Authors: ACN Newswire - Press Releases

Read more //?#

Magazine

Terjebak budaya sungkan: Enggan komplain bisa menghambat perbaikan pelayanan publik

Sejumlah orang sedang menunggu antrean di ruangan di suatu fasilitas pelayanan publik di Jakarta. Zulkarnain.B/Shutterstock● Masih banyak masyarakat enggan komplain karena budaya sungkan dan tid...

Kamu nyaman curhat dengan AI? Hati-hati kena gangguan mental

Seorang perempuan sedang duduk sambil curhat dengan robot humanoid AI di sebuah ruang tamu.VesnaArt/Shutterstock● Kaum muda kini sering menjadikan ‘chatbot’ AI sebagai teman curhat.&...

Cemas saat berulang tahun? Simak tip psikolog untuk hadapi ‘birthday blues’

DavideAngelini/ShutterstockUlang tahun biasanya jadi momen membahagiakan penuh dengan tawa, perayaan, dan hadiah. Namun, tak jarang menjelang ulang tahun, kita justru merasa sedih.Ulang tahun dapat me...